Well, it could be, but they haven't started Phase 1 trials yet, so there is a fair way to go. And even if it goes through all the trials, it has to go up against all the existing therapies out there, which already pull in $1bn p.a.
But good news nonetheless, validates their R&D and collaboration programme.
Well, it could be, but they haven't started Phase 1 trials yet,...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.29M | |||
| Open | High | Low | Value | Volume |
| 3.2¢ | 3.2¢ | 3.1¢ | $37.99K | 1.214M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1147120 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 289141 | 4 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |